Automated Identification of Lesion Activity in Neovascular Age-Related Macular Degeneration

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine · 2011 · 2.6K citations · Full text

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration

Usha Chakravarthy, Simon Harding, Chris Rogers et al. · Ophthalmology · 2012 · 771 citations

Ranibizumab Versus Bevacizumab, Ocular Disease, Ophthalmology +3

Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration

Frank G. Holz, Ramin Tadayoni, Stephen Beatty et al. · British Journal of Ophthalmology · 2014 · 593 citations · Full text

Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol

Karina M. Berg, Terje R. Pedersen, Leiv Sandvik et al. · Ophthalmology · 2014 · 381 citations · Full text

Ocular Disease, Vitreous Body, Ophthalmology +5

Quantitative Classification of Eyes with and without Intermediate Age-related Macular Degeneration Using Optical Coherence Tomography

Sina Farsiu, Stephanie J. Chiu, Rachelle V. O’Connell et al. · Ophthalmology · 2013 · 364 citations · Full text

Ocular Disease, Quantitative Classification, Ophthalmology +5